US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 121.580
  • -7.590-5.88%
Trading Mar 25 14:24 ET
5.93BMarket Cap-20.30P/E (TTM)

Axsome Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
42.53%385.69M
66.04%118.77M
81.27%104.76M
86.65%87.17M
-20.70%75M
440.80%270.6M
193.50%71.53M
243.07%57.79M
429.48%46.7M
94.58M
Operating revenue
42.53%385.69M
66.04%118.77M
81.27%104.76M
86.65%87.17M
-20.70%75M
440.80%270.6M
193.50%71.53M
243.07%57.79M
429.48%46.7M
--94.58M
Cost of revenue
27.77%33.3M
42.50%10.51M
29.16%8.44M
75.15%8.06M
-16.66%6.3M
401.44%26.07M
222.04%7.38M
239.50%6.53M
367.85%4.6M
7.56M
Gross profit
44.11%352.39M
68.74%108.25M
87.91%96.33M
87.91%79.11M
-21.05%68.7M
445.36%244.54M
190.54%64.15M
243.53%51.26M
437.21%42.1M
87.02M
Operating expense
41.50%604.83M
42.50%169.88M
25.53%142.56M
53.30%155M
46.85%137.39M
93.12%427.44M
53.24%119.22M
97.93%113.56M
111.17%101.11M
144.34%93.56M
Selling and administrative expenses
27.31%411.36M
30.48%113.27M
14.88%95.56M
31.19%103.55M
33.40%98.97M
102.90%323.12M
41.16%86.81M
103.43%83.19M
153.32%78.94M
188.64%74.19M
Research and development costs
91.00%187.08M
78.57%55.01M
57.78%45.39M
142.23%49.85M
106.99%36.83M
69.02%97.94M
109.64%30.8M
93.37%28.77M
30.33%20.58M
41.38%17.79M
Depreciation amortization depletion
0.27%6.39M
0.00%1.61M
-0.06%1.61M
0.06%1.59M
1.08%1.59M
54.02%6.38M
0.00%1.61M
0.00%1.61M
71.60%1.59M
--1.57M
-Depreciation and amortization
0.27%6.39M
0.00%1.61M
-0.06%1.61M
0.06%1.59M
1.08%1.59M
54.02%6.38M
0.00%1.61M
0.00%1.61M
71.60%1.59M
--1.57M
Operating profit
-38.01%-252.44M
-11.92%-61.63M
25.79%-46.23M
-28.61%-75.89M
-950.90%-68.69M
-3.63%-182.91M
1.17%-55.07M
-46.75%-62.3M
-47.36%-59M
82.93%-6.54M
Net non-operating interest income expense
-1.80%-6.57M
-214.81%-2.21M
-161.29%-1.98M
52.42%-1.3M
52.21%-1.08M
12.02%-6.45M
46.94%-702K
68.60%-757K
-20.96%-2.73M
-68.58%-2.26M
Non-operating interest expense
1.80%6.57M
214.81%2.21M
161.29%1.98M
-52.42%1.3M
-52.21%1.08M
-12.02%6.45M
-46.94%702K
-68.60%757K
20.96%2.73M
68.58%2.26M
Other net income (expense)
42.51%-28.12M
74.58%-10.99M
-9,206.11%-16.39M
64.32%-2.16M
771.60%1.41M
-1,383.26%-48.92M
-928.74%-43.21M
328.57%180K
-803.84%-6.05M
162K
Special income (charges)
42.51%-28.12M
74.58%-10.99M
-9,206.11%-16.39M
64.32%-2.16M
771.60%1.41M
-1,383.26%-48.92M
-928.74%-43.21M
328.57%180K
-803.84%-6.05M
--162K
-Less:Restructuring and merger&acquisition
-42.51%28.12M
-74.58%10.99M
9,206.11%16.39M
-64.32%2.16M
-771.60%-1.41M
1,383.26%48.92M
928.74%43.21M
-328.57%-180K
803.84%6.05M
---162K
Income before tax
-20.50%-287.13M
24.40%-74.83M
-2.74%-64.6M
-17.05%-79.35M
-691.35%-68.36M
-27.33%-238.28M
-61.62%-98.98M
-40.28%-62.88M
-63.59%-67.79M
78.20%-8.64M
Income tax
-91.15%85K
126.15%85K
0
0
0
960K
-325K
-678K
-617K
2.58M
Net income
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
Net income continuous Operations
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
Minority interest income
Net income attributable to the parent company
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.05%-287.22M
24.06%-74.91M
-3.86%-64.6M
-18.13%-79.35M
-509.35%-68.36M
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
Basic earnings per share
-13.66%-5.99
25.96%-1.54
-1.52%-1.34
-8.44%-1.67
-453.85%-1.44
-14.57%-5.27
-47.52%-2.08
-23.36%-1.32
-45.28%-1.54
74.76%-0.26
Diluted earnings per share
-13.66%-5.99
25.96%-1.54
-1.52%-1.34
-8.44%-1.67
-453.85%-1.44
-14.57%-5.27
-47.52%-2.08
-23.36%-1.32
-45.28%-1.54
74.76%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 42.53%385.69M66.04%118.77M81.27%104.76M86.65%87.17M-20.70%75M440.80%270.6M193.50%71.53M243.07%57.79M429.48%46.7M94.58M
Operating revenue 42.53%385.69M66.04%118.77M81.27%104.76M86.65%87.17M-20.70%75M440.80%270.6M193.50%71.53M243.07%57.79M429.48%46.7M--94.58M
Cost of revenue 27.77%33.3M42.50%10.51M29.16%8.44M75.15%8.06M-16.66%6.3M401.44%26.07M222.04%7.38M239.50%6.53M367.85%4.6M7.56M
Gross profit 44.11%352.39M68.74%108.25M87.91%96.33M87.91%79.11M-21.05%68.7M445.36%244.54M190.54%64.15M243.53%51.26M437.21%42.1M87.02M
Operating expense 41.50%604.83M42.50%169.88M25.53%142.56M53.30%155M46.85%137.39M93.12%427.44M53.24%119.22M97.93%113.56M111.17%101.11M144.34%93.56M
Selling and administrative expenses 27.31%411.36M30.48%113.27M14.88%95.56M31.19%103.55M33.40%98.97M102.90%323.12M41.16%86.81M103.43%83.19M153.32%78.94M188.64%74.19M
Research and development costs 91.00%187.08M78.57%55.01M57.78%45.39M142.23%49.85M106.99%36.83M69.02%97.94M109.64%30.8M93.37%28.77M30.33%20.58M41.38%17.79M
Depreciation amortization depletion 0.27%6.39M0.00%1.61M-0.06%1.61M0.06%1.59M1.08%1.59M54.02%6.38M0.00%1.61M0.00%1.61M71.60%1.59M--1.57M
-Depreciation and amortization 0.27%6.39M0.00%1.61M-0.06%1.61M0.06%1.59M1.08%1.59M54.02%6.38M0.00%1.61M0.00%1.61M71.60%1.59M--1.57M
Operating profit -38.01%-252.44M-11.92%-61.63M25.79%-46.23M-28.61%-75.89M-950.90%-68.69M-3.63%-182.91M1.17%-55.07M-46.75%-62.3M-47.36%-59M82.93%-6.54M
Net non-operating interest income expense -1.80%-6.57M-214.81%-2.21M-161.29%-1.98M52.42%-1.3M52.21%-1.08M12.02%-6.45M46.94%-702K68.60%-757K-20.96%-2.73M-68.58%-2.26M
Non-operating interest expense 1.80%6.57M214.81%2.21M161.29%1.98M-52.42%1.3M-52.21%1.08M-12.02%6.45M-46.94%702K-68.60%757K20.96%2.73M68.58%2.26M
Other net income (expense) 42.51%-28.12M74.58%-10.99M-9,206.11%-16.39M64.32%-2.16M771.60%1.41M-1,383.26%-48.92M-928.74%-43.21M328.57%180K-803.84%-6.05M162K
Special income (charges) 42.51%-28.12M74.58%-10.99M-9,206.11%-16.39M64.32%-2.16M771.60%1.41M-1,383.26%-48.92M-928.74%-43.21M328.57%180K-803.84%-6.05M--162K
-Less:Restructuring and merger&acquisition -42.51%28.12M-74.58%10.99M9,206.11%16.39M-64.32%2.16M-771.60%-1.41M1,383.26%48.92M928.74%43.21M-328.57%-180K803.84%6.05M---162K
Income before tax -20.50%-287.13M24.40%-74.83M-2.74%-64.6M-17.05%-79.35M-691.35%-68.36M-27.33%-238.28M-61.62%-98.98M-40.28%-62.88M-63.59%-67.79M78.20%-8.64M
Income tax -91.15%85K126.15%85K000960K-325K-678K-617K2.58M
Net income -20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M
Net income continuous Operations -20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M
Minority interest income
Net income attributable to the parent company -20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.05%-287.22M24.06%-74.91M-3.86%-64.6M-18.13%-79.35M-509.35%-68.36M-27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M
Basic earnings per share -13.66%-5.9925.96%-1.54-1.52%-1.34-8.44%-1.67-453.85%-1.44-14.57%-5.27-47.52%-2.08-23.36%-1.32-45.28%-1.5474.76%-0.26
Diluted earnings per share -13.66%-5.9925.96%-1.54-1.52%-1.34-8.44%-1.67-453.85%-1.44-14.57%-5.27-47.52%-2.08-23.36%-1.32-45.28%-1.5474.76%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More